BHWM
TEVA icon

Bay Harbor Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bay Harbor Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-77
Closed -$1K – 398
2020
Q4 		$1K Hold
77
– – ﹤0.01% 400
2020
Q3 		$1K Hold
77
– – ﹤0.01% 360
2020
Q2 		$1K Hold
77
– – ﹤0.01% 330
2020
Q1 		$1K Hold
77
– – ﹤0.01% 321
2019
Q4 		$1K Hold
77
– – ﹤0.01% 327
2019
Q3 		$1K Sell
77
-34
-31% -$260 ﹤0.01% 345
2019
Q2 		$1K Buy
111
+34
+44% +$410 ﹤0.01% 341
2019
Q1 		$1K Hold
77
– – ﹤0.01% 374
2018
Q4 		$1K Buy
+77
New +$1.58K ﹤0.01% 367

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Bay Harbor Wealth Management's TEVA Position: Q1 2021 in Review

Bay Harbor Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2021, closing a stake of 77 shares — an estimated $1K sold.

Bay Harbor Wealth Management first reported a position in TEVA in Q4 2018 and held it in 9 quarters. The position peaked at $1K in Q4 2020. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

  • Bay Harbor Wealth Management reported no remaining Teva Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 77 Teva Pharmaceuticals shares in Q1 2021, an estimated $1K.
  • Bay Harbor Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 9 quarters.
  • Bay Harbor Wealth Management's Teva Pharmaceuticals position peaked at $1K in Q4 2020.
  • 451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2021.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2021, filed 5 May 2021.